Related Experiment Video
Updated: Aug 10, 2025

06:19
A Rat Model of Mild Intrauterine Hypoperfusion with Microcoil Stenosis
Published on: January 7, 2018
10.4K
Elective Cesarean Section during Preterm Prevents Pulmonary Hypoplasia Development in Potter Sequence
Yuya Kinoshita1, Rieko Sakamoto1, Yusuke Hattori1
1Department of Pediatrics, Graduate School of Medicine Sciences, Kumamoto University, Kumamoto, Japan.
Case Reports in Pediatrics
|February 10, 2023
Summary
Potter sequence, a rare condition, involves kidney and lung development issues. Early cesarean delivery at 34 weeks in a case study improved lung development, enabling survival and discharge after 169 days.
Area of Science:
- Perinatology
- Neonatology
- Pediatric Nephrology
Background:
- Potter syndrome, characterized by bilateral renal aplasia, leads to oligohydramnios, pulmonary hypoplasia, and distinctive facial and limb anomalies.
- Potter sequence encompasses similar manifestations but arises from various causes of oligohydramnios, presenting diagnostic and management challenges.
- Current guidelines for optimal delivery timing and postpartum care in Potter sequence are limited.
Observation:
- A case of Potter sequence was managed, involving a fetus with oligohydramnios, unilateral kidney agenesis, and contralateral multicystic dysplastic kidney.
- Prenatal imaging revealed significant pulmonary hypoplasia, with a low fetal lung volume to body weight ratio.
- The fetus experienced persistent oligohydramnios, suspected to impede lung growth.
Findings:
- Elective cesarean delivery was performed at 34 weeks gestation.
- Postnatal management included intensive respiratory support, dialysis, and nutritional therapy.
- The infant survived and was discharged at 169 days of age.
Implications:
- Early elective cesarean delivery in premature births complicated by Potter sequence may mitigate pulmonary hypoplasia progression.
- Aggressive multidisciplinary postpartum management is crucial for stabilizing affected infants.
- Further research is essential to establish evidence-based protocols for Potter sequence management and improve outcomes.

